Beyond the Pack
Serialized packaging is not the only way to deter counterfeiters – integrated authentication technologies are here to help
Kelly Boyer | | Longer Read
This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques. Read more about The Small Molecule Manufacturer here https://themedicinemaker.com/manufacture/small-but-never-forgotten
The counterfeit drug trade costs the pharmaceutical industry around $200 billion each year, but although the financial loss can be quantified, the impact of human life is much more difficult to measure. Counterfeiters exploit our basic human need to access essential medicines. And whether they are targeting patented drugs or generics, manufacturers of fake drugs have developed sophisticated ways to exploit consumers’ vulnerabilities. Counterfeiters have an arsenal of techniques that they rely on to dupe consumers – and their experience in making fake products means that they aim to copy the shape, color, and size of various medicines. The active pharmaceutical ingredient (API), however, may be at the wrong strength, not present at all, or be a completely different active ingredient or even toxic material.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine